Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...

Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...

Acute respiratory distress syndrome, also known as ARDS, is a common killer among critically ill patients hospitalized with COVID-19. But even if they survive, it’s a long road to recovery. Patients ...

The benefits of early continuous neuromuscular blockade in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation remain unclear. We randomly assigned ...

Trimethoprim-sulfamethoxazole (TMP-SMX) treatment may be linked to the onset of severe acute respiratory distress syndrome (ARDS) in adolescents, according to a recent case series published online May ...

A number of concurrent risk factors are associated with development of the acute respiratory distress syndrome (ARDS). One such risk factor might be asymptomatic respiratory viral infection — for ...

Basophils, a type of white blood cell, promote recovery from acute respiratory distress syndrome (ARDS) in mice, according to researchers at Science Tokyo. In a mouse model of ARDS, basophils were ...